AB InBev promotes beer as a moderate choice with expanded low- and no-alcohol offerings

Michel Doukeris CEO Anheuser-Busch InBev SA/NV
Michel Doukeris CEO - Anheuser-Busch InBev SA/NV
0Comments

AB InBev is promoting beer as a drink of moderation, highlighting its lower alcohol-by-volume compared to other alcoholic beverages. The company aims to offer consumers a variety of choices, including low- and no-alcohol options.

In October, AB InBev celebrated Global Beer Responsible Day by organizing events in retail shops, pubs, bars, and restaurants worldwide. Employees and partners shared tips for responsible drinking, offered samples of no-alcohol beers, and held brand experiences focused on moderation.

The company’s Global Innovation and Technology Center (GITEC) in Belgium hosted media and stakeholders to showcase advancements in the flavor profile of no-alcohol beers. David De Schutter, Global Vice President of GITEC, said: “AB InBev is constantly looking for new ways to innovate. Our brewers and scientists are crafting high-quality, no-alcohol beers with their own unique taste and character – from Jupiler 0.0, which was named the world’s best no-alcohol lager, to Corona Cero, the Global Beer Sponsor of the Olympic Games Paris 2024.”

AB InBev is one of the largest producers of no-alcohol beer globally, offering 29 brands across more than 45 markets. The company has invested over $1 billion in marketing campaigns that promote social norms around responsible drinking. It also supports technology platforms aimed at reducing harmful drinking and trains servers at global events to encourage moderation.

As a global sponsor of the International Olympic Committee, AB InBev used events such as the Paris 2024 Olympic Games to highlight its portfolio of low- and no-alcohol beers. The company plans similar initiatives for the Milano-Cortina Winter Games in 2026.

Throughout October, AB InBev continues its efforts both online and in-person to encourage consumers worldwide to see beer as a beverage suited for moderation.



Related

Paul Hudson Chief Executive Officer Sanofi SA

Acoziborole receives key EU panel backing as single-dose treatment for sleeping sickness

Acoziborole Winthrop, a new oral treatment for sleeping sickness developed by the Drugs for Neglected Diseases initiative (DNDi) and Sanofi, has received a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for…

Martin Lundstedt President and CEO at Volvo Group North America LLC Volvo Group North America LLC

Volvo announces updated share and vote count after series conversion

The number of votes in AB Volvo has changed following the conversion of 2,000,619 Series A shares into an equal number of Series B shares.

Paul Hudson Chief Executive Officer Sanofi SA

Sanofi and Regeneron’s Dupixent recommended for EU approval in young children with chronic urticaria

Sanofi and Regeneron have announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of Dupixent (dupilumab) for children aged two to 11 years with…

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from EU Business Daily.